| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/19/2007 | WO2007044856A1 Device and method for high-throughput stimulation, immunostaining, and visualization of single cells |
| 04/19/2007 | WO2007044695A2 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 04/19/2007 | WO2007044620A2 Optimal polyvalent vaccine for cancer |
| 04/19/2007 | WO2007044607A2 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 04/19/2007 | WO2007044571A2 Methods for identifying proteins essential for human cell proliferation and therapeutic agents that target them |
| 04/19/2007 | WO2007044522A1 P62 as a risk determinant for metabolic syndrome |
| 04/19/2007 | WO2007044438A2 Diagnosis and prevention of fetal heart disease |
| 04/19/2007 | WO2007044308A1 Acoustic oil quality sensor for permanent applications |
| 04/19/2007 | WO2007044306A1 Acoustic engine wear and oil quality sensor |
| 04/19/2007 | WO2007044154A1 Method for determining chlorine demand in water |
| 04/19/2007 | WO2007044094A1 Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb) |
| 04/19/2007 | WO2007044086A2 Affinity-based detection of biological targets |
| 04/19/2007 | WO2007044025A2 Method for detecting analytes based on evanescent illumination and scatter-based detection of nonoparticle probe complexes |
| 04/19/2007 | WO2007043998A1 Alzheimer’s disease-specific alterations of the erk1/erk2 phosphorylation ratio |
| 04/19/2007 | WO2007043973A1 Method of enhancing a fluorescent signal |
| 04/19/2007 | WO2007043736A1 Novel iminecalixarene derivatives and aminocalixarene derivatives, method of preparation thereof, and self-assembled monolayer prepared by the method, fixing method of oligo-dna by using the self-assembled monolayer, and oligo-dna chip prepared by the method |
| 04/19/2007 | WO2007043715A1 Rna-binding peptide |
| 04/19/2007 | WO2007043640A1 Substance for use in treatment or prevention of hcv infection |
| 04/19/2007 | WO2007043635A1 Preventive/remedy for cancer |
| 04/19/2007 | WO2007043589A1 Animal model of schizophrenia |
| 04/19/2007 | WO2007043582A1 Method for determination of sars virus nucleocapsid protein, reagent kit for the determination, test device, monoclonal antibody directed against sars virus nucleocapsid protein, and hybridoma capable of producing the monoclonal antibody |
| 04/19/2007 | WO2007043531A1 Genetic marker for use in diagnosis of sensitivity to anti-tumor agent or concurrent chemoradiation therapy, and use thereof |
| 04/19/2007 | WO2007043498A1 Substrate with binding functional group |
| 04/19/2007 | WO2007043418A1 Method for prediction of postoperative prognosis for patient with pulmonary adenocarcinoma, and composition for use in the prediction |
| 04/19/2007 | WO2007043295A1 Method of identifying compounds inhibiting ddx39 |
| 04/19/2007 | WO2007043287A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR Ϝ-CHAIN |
| 04/19/2007 | WO2007043103A1 Method of diagnosing sjoegren’s syndrome and diagnosis kit |
| 04/19/2007 | WO2007043054A1 Treatment and monitoring disease state of liver cancer |
| 04/19/2007 | WO2007042942A2 Method and device to recognize nerve injuries, specifically brachial plexus injuries and their severity |
| 04/19/2007 | WO2007042897A1 Method for the differential diagnosis and the monitoring of alzheimer-type dementia |
| 04/19/2007 | WO2007042827A2 Treatment and diagnosis of obligate intracellular pathogens |
| 04/19/2007 | WO2007042805A1 Apparatus and method for measuring hydrogen concentration |
| 04/19/2007 | WO2007042792A1 Gpr 146 receptor |
| 04/19/2007 | WO2007042778A2 Monitoring cardiovascular disease by determining the expression of kir2ds2 and/or dap12 |
| 04/19/2007 | WO2007042776A1 Modulators of the purinergic signalling pathway for treating sodium homeostatsis, hypertension and aldosteronism |
| 04/19/2007 | WO2007042771A1 Three hybrid screening assay using reverse transfected mammalian cell arrays |
| 04/19/2007 | WO2007042746A2 Ion source preparation system |
| 04/19/2007 | WO2007042606A1 Measuring method, arrangement and software product |
| 04/19/2007 | WO2007042568A1 Method and means for determining the replication rate of a viral population |
| 04/19/2007 | WO2007042501A1 Probe, sensor and measurement method |
| 04/19/2007 | WO2007042289A2 Nanobodies™ and polypeptides against egfr and igf-ir |
| 04/19/2007 | WO2007042286A1 Egfr dependent modulation of chemokine expression and influence on therapy and diagnosis of tumors and side effects thereof |
| 04/19/2007 | WO2007042256A1 Non-invasive in vitro method to detect transitional cell carcinoma of the bladder |
| 04/19/2007 | WO2007042051A1 A measuring device and a method for determination of at least one chemical property in an oil and a data storing device obtainable by said method |
| 04/19/2007 | WO2007041999A1 Device for qualitatively and/or quantitatively determining ir active constituents in liquids and a method for qualitatively and/or quantitatively determining ir active constituents in liquids |
| 04/19/2007 | WO2007041987A2 Method and device for rapid testing of the quality of cereals, grits and flours by measuring the aggregation of gluten |
| 04/19/2007 | WO2007041889A1 Standard moisture correction |
| 04/19/2007 | WO2007041868A1 Method for detecting a biomarker of oxidative stress in a biological sample |
| 04/19/2007 | WO2007041846A1 Ste11p/ste50p related yeast two-hybrid and one-hybrid systems |
| 04/19/2007 | WO2007041755A1 Hyperspectral imaging of contaminants in products and processes of agriculture |
| 04/19/2007 | WO2007041734A2 Device for the analysis of liquid samples |
| 04/19/2007 | WO2007024535A3 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007024535A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007021683A3 Human cell clones useful for functional analyses of the biological activity of an endogeneous urotensin ii receptor and uses thereof |
| 04/19/2007 | WO2007016529A3 Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy |
| 04/19/2007 | WO2007016178A3 Bgt1 transporters expressed in blood brain barrier cells |
| 04/19/2007 | WO2007015697A9 Method for enhancing two-dimensional gel electrophoresis resolution |
| 04/19/2007 | WO2007014992A3 Antibodies directed against an ldl receptor |
| 04/19/2007 | WO2007014390A3 Methods of targeting baff |
| 04/19/2007 | WO2007014344A3 Detection and measurement of blood-feeding activity |
| 04/19/2007 | WO2007002535A8 Biomarkers for ovarian cancer |
| 04/19/2007 | WO2007001436A3 Surface modification for non-specific adsorption of biological material |
| 04/19/2007 | WO2007001264A9 Method of making recombinant human antibodies for use in biosensor technology |
| 04/19/2007 | WO2006134390A3 Method for diagnosing neurodegenerative disease |
| 04/19/2007 | WO2006129038A3 Method for quantifying living coliform microorganisms in a water sample |
| 04/19/2007 | WO2006119312A3 Method for determination of fuel thermal stability |
| 04/19/2007 | WO2006119160A3 Polymer conjugate enhanced bioassays |
| 04/19/2007 | WO2006116541A3 Tat-002 and methods of assessing and treating cancer |
| 04/19/2007 | WO2006116361A3 Methods and devices for monitoring platelet function |
| 04/19/2007 | WO2006113494A3 Debulking catheters and methods |
| 04/19/2007 | WO2006113251A3 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 04/19/2007 | WO2006113245A3 Methods for measuring glycan levels of proteins |
| 04/19/2007 | WO2006107962A9 Methods and products for evaluating an immune response to a therapeutic protein |
| 04/19/2007 | WO2006098849A3 Method and device for detecting feline immunodeficiency virus |
| 04/19/2007 | WO2006095257A3 Microarray device for dna recognition, apparatus using the microarray device, and corresponding method of operation |
| 04/19/2007 | WO2006091673A3 Crystal structure of tak1-tab1 |
| 04/19/2007 | WO2006089801A8 Method for the redox potential-dependent detection of target molecules by interactive peptides |
| 04/19/2007 | WO2006088925A3 Use of il17-f in diagnosis and therapy of airway inflammation |
| 04/19/2007 | WO2006087163A3 Novel in vitro methods for studying receptors recognizing volatile compounds |
| 04/19/2007 | WO2006078942A3 Regulation of protein synthesis by inhibition of eif4e-eif4g interaction |
| 04/19/2007 | WO2006053155A3 Gp202: methods and compositions for treating cancer |
| 04/19/2007 | WO2006052731A3 Molecular indicators of breast cancer prognosis and prediction of treatment response |
| 04/19/2007 | WO2006047451A3 Immunoassays for lamotrigine |
| 04/19/2007 | WO2006040153A3 Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease |
| 04/19/2007 | WO2006029052A8 Methods for assessing atherosclerosis |
| 04/19/2007 | WO2006028790A3 Test cell for evaluating phosphor |
| 04/19/2007 | WO2006023574A3 Methods for describing a group of chemical structures |
| 04/19/2007 | WO2006012486A3 Immunoassay assembly and methods of use |
| 04/19/2007 | WO2005116598A3 Imaging method and apparatus |
| 04/19/2007 | WO2005116266A3 Methods of amplifying infectious proteins |
| 04/19/2007 | WO2005116237A3 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
| 04/19/2007 | WO2005112554A3 Handheld medical logging apparatus and method |
| 04/19/2007 | WO2005111234A3 Methods of using zc1 and zc3 kinase substrate phosphorylation as biomarkers |
| 04/19/2007 | WO2005079277A3 High throughput screening methods for lubricating oil compositions |
| 04/19/2007 | WO2005056802A3 Materials and methods relating to cell cycle control |
| 04/19/2007 | WO2005024352A3 Apparatus and method for real time determination of density and related parameters in manufacturing processes |
| 04/19/2007 | WO2005020796A3 Two-part drug discovery system |
| 04/19/2007 | WO2004098537A3 Activation agents on the surface of encapsulation vesicles |
| 04/19/2007 | WO2004091475A3 Gaucher disease drugs and methods of identifying same |
| 04/19/2007 | WO2004088279A3 Allosteric probes and methods |